Abnormalities in the Her-2 gene are closely related to the severity of many epithelial cell cancers, with tumours exhibiting strong metastatic and invasive capabilities, poor sensitivity to chemotherapy, and a high tendency for recurrence. This evidence concerns the gene ERBB2 and neoplasm.